SBIR/STTR Research Award
ORGANI PRESERVATION WITH A RED BLOOD CELL SUBSTITUTE
Award amount
$49,540Program and phase
SBIR · Phase IAward year
1992Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- BIOPURE CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
SAFE HYPOTHERMIC STORAGE OF ISLATED LIVERS IS CURRENTLY LIMITED TO LESS THAN 24 HOURS. INCREASED O2 DELIVERY BY A HEMOGLOBIN-BASED OXYGEN CARRIER DURING COOLING MAY REDUCE HYPOXIA RELATED ENDOTHELIAL CELL DAMAGE AND ENHANCE ORGAN SURVIVAL. WE WILL COMPARE HEPATIC BIOCHEMICAL AND PHYSIOLOGICAL FUNCTION DURING NORMOTHERMIC (37 DEGREE C) PERFUSION OF LIVERS THAT HAVE BEEN HYPOTHERMICALLY STORED FOR 24 HOURS IN THE PRESENCE OF CURRENT STORAGE SOLUTIONS OR A RED BLOOD CELL SUBSTITUTE MADE UP OF ULTRAPURE POLYMERIZED BOVINE HEMOGLOBIN. DONOR LIVERS, OBTAINED FROM NORMAL FED RATS, WILL BE ASSESSED FOR BILIARY EXCRETION, O2 UTILIZATION, PRODUCTION OF GLUCOSE, LACTATE, AMINO ACID N, UREA N, RELEASE OF K+ AND TISSUE INJURY ENZYMES (LACTODEHYDROGENASE, TRANSAMINASES), RESIDUAL HEPATIC GLYCOGEN, ATP CONTENT AND HISTOLOGICAL CHANGES TO DELINEATE THE EXTENT OF HEPATOCELLULAR INJURY WITH EACH SOLUTION. THIS WILL DEFINE THE SUCCESS OF EXTENDING HYPO THERMIC PRESERVATION OF LIVERS (AND PRESUMABLY OTHER ORGANS) WITH AN OXYGEN CARRYING SOLUTION.
Technology keywords
Not reported